Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Nath Bio-Genes (India) Statistics

Total Valuation

NSE:NATHBIOGEN has a market cap or net worth of INR 2.82 billion. The enterprise value is 4.36 billion.

Market Cap	2.82B
Enterprise Value	4.36B

Important Dates

The last earnings date was Saturday, January 31, 2026.

Earnings Date	Jan 31, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

NSE:NATHBIOGEN has 19.00 million shares outstanding. The number of shares has decreased by -0.82% in one year.

Current Share Class	19.00M
Shares Outstanding	19.00M
Shares Change (YoY)	-0.82%
Shares Change (QoQ)	-2.85%
Owned by Insiders (%)	9.57%
Owned by Institutions (%)	2.23%
Float	6.28M

Valuation Ratios

The trailing PE ratio is 6.53.

PE Ratio	6.53
Forward PE	n/a
PS Ratio	0.63
PB Ratio	0.41
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	10.11
EV / Sales	0.98
EV / EBITDA	8.81
EV / EBIT	9.63
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.23
Debt / EBITDA	3.13
Debt / FCF	n/a
Interest Coverage	3.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.10%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.08%
Revenue Per Employee	9.88M
Profits Per Employee	956,100
Employee Count	451
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:NATHBIOGEN has paid 28.01 million in taxes.

Income Tax	28.01M
Effective Tax Rate	6.10%

Stock Price Statistics

The stock price has decreased by -9.82% in the last 52 weeks. The beta is 0.48, so NSE:NATHBIOGEN's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-9.82%
50-Day Moving Average	150.36
200-Day Moving Average	172.40
Relative Strength Index (RSI)	48.06
Average Volume (20 Days)	19,169

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NATHBIOGEN had revenue of INR 4.46 billion and earned 431.20 million in profits. Earnings per share was 22.69.

Revenue	4.46B
Gross Profit	3.18B
Operating Income	452.63M
Pretax Income	459.21M
Net Income	431.20M
EBITDA	494.37M
EBIT	452.63M
Earnings Per Share (EPS)	22.69

Balance Sheet

The company has 7.42 million in cash and 1.55 billion in debt, with a net cash position of -1.54 billion or -81.08 per share.

Cash & Cash Equivalents	7.42M
Total Debt	1.55B
Net Cash	-1.54B
Net Cash Per Share	-81.08
Equity (Book Value)	6.80B
Book Value Per Share	345.69
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 71.26%, with operating and profit margins of 10.16% and 9.68%.

Gross Margin	71.26%
Operating Margin	10.16%
Pretax Margin	10.31%
Profit Margin	9.68%
EBITDA Margin	11.09%
EBIT Margin	10.16%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.35%.

Dividend Per Share	2.00
Dividend Yield	1.35%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.82%
Shareholder Yield	2.17%
Earnings Yield	15.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1